USP53 and breast cancer: Further, GEPIA2, Kaplan-Meier Plotter, TCGA and GTEx databases were used to jointly analyze the expression of USP53 in pancarcinoma and corresponding normal tissues, and the cancer types with statistical differences in the four analyses were selected, including breast cancer with low expression of USP53.